At the end of Q3 2024, shares of Tilray Brands, Inc. (NASDAQ:TLRY) were held by 16 hedge funds in the IM database with a total stake value of $20.62 million, up 36% from the previous quarter.

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried ...

CBD ratio that has become in demand in Germany. Tilray THC10 CBD10 (10ml): A new trial size version of Tilray Medical’s top selling medical cannabis extract, responding to patients and ...

In a little more than two years, more than 100 hemp-derived delta-9 products have become available online, according to a CBD ...